There are two simple reasons for these high costs: a lack of generic-drug competition, and pharmaceutical companies' success in marketing their brand-name drugs.
Sign Up for e-mail newsletters
Stay up to date on the coronavirus outbreak by signing up to our newsletter today.
Thank you for signing up to Live Science. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.